Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Daniel James Salas-Escabillas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0819-989X; OpenAlex author ID A5033675601; NIH RePORTER profile ID 16027659. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
44
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 grant · 2025: 3 papers · 2026: 1 paper

Papers 7

  1. Spatial Transcriptomics on a Diverse Pancreatic Cancer Cohort Reveals Race-Related Differences in Tumor Subtypes and Immune Microenvironments. First author DOI 10.1158/0008-5472.can-25-2748↗
  2. Tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer. Co-author DOI 10.1016/j.devcel.2024.12.003↗
  3. Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion. Co-author DOI 10.1126/scitranslmed.ady7524↗
  4. Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells. Co-author DOI 10.1158/1078-0432.ccr-24-2183↗
  5. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Co-author DOI 10.7554/elife.80721↗
  6. Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. Co-author DOI 10.1371/journal.pgen.1010315↗
  7. The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice. Co-author DOI 10.1016/j.jcmgh.2020.08.011↗

Grants 1

  1. Understanding the Fate of Metaplastic Tuft Cells in the Progression of Pancreatic Cancer F31CA271576↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Howard C. Crawford · 6 shared papers, 2021–2026 · strength 0.97
  2. Nina G. Steele · 5 shared papers, 2021–2026 · strength 0.83
  3. Debora Barbosa Vendramini Costa · 2 shared papers, 2025–2026 · strength 0.38
  4. Ling Huang · 2 shared papers, 2025–2026 · strength 0.38
  5. Ralph A. Francescone III · 2 shared papers, 2025–2026 · strength 0.38
  6. Ian M. Loveless · 2 shared papers, 2025–2026 · strength 0.38
  7. David Kwon · 2 shared papers, 2025–2026 · strength 0.38
  8. Yuesong Wu · 2 shared papers, 2025–2026 · strength 0.38
  9. Kailee M. Hartway · 2 shared papers, 2025–2026 · strength 0.38
  10. Yaqing Zhang · 3 shared papers, 2021–2023 · strength 0.38
  11. Marina Pasca di Magliano · 3 shared papers, 2021–2023 · strength 0.38
  12. Filip Bednar · 3 shared papers, 2021–2023 · strength 0.38
  13. Jacob T. Mitchell · 2 shared papers, 2025 · strength 0.38
  14. Elana Judith Fertig · 2 shared papers, 2025 · strength 0.38
  15. Luciane Tsukamoto Kagohara · 2 shared papers, 2025 · strength 0.38
  16. Megan T. Hoffman · 2 shared papers, 2021–2025 · strength 0.32
  17. Simone Benitz · 2 shared papers, 2021–2025 · strength 0.32
  18. Samantha B. Kemp · 2 shared papers, 2021–2025 · strength 0.29
  19. Rosa Elena Menjivar · 2 shared papers, 2022–2023 · strength 0.26
  20. Zeribe C. Nwosu · 2 shared papers, 2022–2023 · strength 0.26
  21. Bin Chen · 1 shared paper, 2026 · strength 0.21
  22. Kathleen E. DelGiorno · 1 shared paper, 2025 · strength 0.21
  23. Rosalie C. Sears · 1 shared paper, 2025 · strength 0.21
  24. Brittany L. Allen-Petersen · 1 shared paper, 2025 · strength 0.21
  25. Robert A. Anders · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.